DDIT3 Antikörper (Ala135, C-Term) (APC)
-
- Target Alle DDIT3 Antikörper anzeigen
- DDIT3 (DNA-Damage-Inducible Transcript 3 (DDIT3))
-
Bindungsspezifität
- AA 120-149, Ala135, C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DDIT3 Antikörper ist konjugiert mit APC
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS)
- Kreuzreaktivität
- Human, Maus
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
- Produktmerkmale
- DDIT3, CT (A135) (DDIT3, CHOP, CHOP10, GADD153, DNA damage-inducible transcript 3 protein, C/EBP-homologous protein, C/EBP-homologous protein 10, Growth arrest and DNA damage-inducible protein GADD153) (APC)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 120-149 in the C-terminal region of human DDIT3, UniProt Accession #P35638. Species sequence homology: bovine, hamster
- Isotyp
- IgG
- Top Product
- Discover our top product DDIT3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- 4°C ,Do Not Freeze
-
- Target
- DDIT3 (DNA-Damage-Inducible Transcript 3 (DDIT3))
- Andere Bezeichnung
- DDIT3 (DDIT3 Produkte)
- NCBI Accession
- NP_004074
- UniProt
- P35638
- Pathways
- Regulation of Muscle Cell Differentiation, ER-Nucleus Signaling, Skeletal Muscle Fiber Development, Cell RedoxHomeostasis
-